ALKS Covered Call Strategy
ALKS (Alkermes plc), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
ALKS (Alkermes plc) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.49B, a trailing P/E of 42.34, a beta of 0.26 versus the broader market, a 52-week range of 25.17-39.56, average daily share volume of 2.4M, a public-listing history dating back to 1991, approximately 2K full-time employees. These structural characteristics shape how ALKS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.26 indicates ALKS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 42.34 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a covered call on ALKS?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current ALKS snapshot
As of May 15, 2026, spot at $37.66, ATM IV 38.80%, IV rank 10.25%, expected move 11.12%. The covered call on ALKS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this covered call structure on ALKS specifically: ALKS IV at 38.80% is on the cheap side of its 1-year range, which means a premium-selling ALKS covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 11.12% (roughly $4.19 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ALKS expiries trade a higher absolute premium for lower per-day decay. Position sizing on ALKS should anchor to the underlying notional of $37.66 per share and to the trader's directional view on ALKS stock.
ALKS covered call setup
The ALKS covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ALKS near $37.66, the first option leg uses a $40.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ALKS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ALKS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $37.66 | long |
| Sell 1 | Call | $40.00 | $0.93 |
ALKS covered call risk and reward
- Net Premium / Debit
- -$3,673.50
- Max Profit (per contract)
- $326.50
- Max Loss (per contract)
- -$3,672.50
- Breakeven(s)
- $36.73
- Risk / Reward Ratio
- 0.089
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
ALKS covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on ALKS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$3,672.50 |
| $8.34 | -77.9% | -$2,839.93 |
| $16.66 | -55.8% | -$2,007.35 |
| $24.99 | -33.7% | -$1,174.78 |
| $33.31 | -11.5% | -$342.21 |
| $41.64 | +10.6% | +$326.50 |
| $49.96 | +32.7% | +$326.50 |
| $58.29 | +54.8% | +$326.50 |
| $66.62 | +76.9% | +$326.50 |
| $74.94 | +99.0% | +$326.50 |
When traders use covered call on ALKS
Covered calls on ALKS are an income strategy run on existing ALKS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
ALKS thesis for this covered call
The market-implied 1-standard-deviation range for ALKS extends from approximately $33.47 on the downside to $41.85 on the upside. A ALKS covered call collects premium on an existing long ALKS position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether ALKS will breach that level within the expiration window. Current ALKS IV rank near 10.25% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ALKS at 38.80%. As a Healthcare name, ALKS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ALKS-specific events.
ALKS covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ALKS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ALKS alongside the broader basket even when ALKS-specific fundamentals are unchanged. Short-premium structures like a covered call on ALKS carry tail risk when realized volatility exceeds the implied move; review historical ALKS earnings reactions and macro stress periods before sizing. Always rebuild the position from current ALKS chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on ALKS?
- A covered call on ALKS is the covered call strategy applied to ALKS (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With ALKS stock trading near $37.66, the strikes shown on this page are snapped to the nearest listed ALKS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ALKS covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the ALKS covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 38.80%), the computed maximum profit is $326.50 per contract and the computed maximum loss is -$3,672.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ALKS covered call?
- The breakeven for the ALKS covered call priced on this page is roughly $36.73 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ALKS market-implied 1-standard-deviation expected move is approximately 11.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on ALKS?
- Covered calls on ALKS are an income strategy run on existing ALKS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current ALKS implied volatility affect this covered call?
- ALKS ATM IV is at 38.80% with IV rank near 10.25%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.